HR 1628 · 118th Congress 2023–2025, ended

CBD Product Safety and Standardization Act of 2023

Latest action · Mar 24, 2023 Referred to the Subcommittee on Health.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedMar 17, 2023
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

CBD Product Safety and Standardization Act of 2023

This bill requires the Food and Drug Administration (FDA) to regulate food containing cannabidiol (CBD) derived from hemp as a food additive. (The FDA has determined that food containing added CBD cannot be sold in interstate commerce.)

Under this bill, in order to be sold, a food containing CBD derived from hemp must conform with current FDA requirements pertaining to food additives or be generally recognized as safe (GRAS). (Under current law, a food additive with the GRAS designation is not subject to FDA premarket review and approval requirements.)

In addition, such a food must comply with all other relevant FDA and labeling requirements.

Such a food shall be exempt from an existing provision that prohibits the sale of a food containing an additive that is (1) an FDA-approved drug or biological product, or (2) subject to certain clinical investigations.

The FDA must issue regulations pertaining to such foods that specify (1) the maximum amount of CBD derived from hemp per serving, (2) labeling and packaging requirements, and (3) any conditions for intended use.

Cosponsors 12

Members who signed on, in the order they did. Signatures ran from Mar 17, 2023 to Feb 15, 2024; 4 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
D-MNAngie CraigOriginalMar 17, 2023
D-NVDina TitusOriginalMar 17, 2023
R-WIGlenn GrothmanOriginalMar 17, 2023
D-WIMark PocanOriginalMar 17, 2023
R-KYJames ComerMar 28, 2023
D-CATony CárdenasApr 13, 2023
D-GADavid ScottApr 25, 2023
R-KYAndy BarrApr 27, 2023
D-NHAnn M. KusterJul 13, 2023
D-KYMorgan McGarveyJul 17, 2023
R-TXDan CrenshawJul 24, 2023
D-COJason CrowFeb 15, 2024

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
HouseEnergy and Commerce Committee
Referred Mar 17, 2023
Health Subcommittee
Referred Mar 24, 2023

Actions 3

Everything that happened, newest first.

  1. Mar 24, 2023Referred to the Subcommittee on Health.
  2. Mar 17, 2023Introduced in House
  3. Mar 17, 2023Referred to the House Committee on Energy and Commerce.

Research

What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

Constitutional authority

Congress has the power to enact this legislation pursuant to the following: This bill is enacted pursuant to the power granted to Congress under Article I, Section 8 of the United States Constitution The single subject of this legislation is: Health Care

The sponsor’s statement, as printed in the Congressional Record, vol. 169, no. 50, March 17, 2023, page H1295.

Printed hearings 1

Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

NumberHearingCommitteeHeld
Serial No. 118-57HEMP IN THE MODERN WORLD: THE YEARSLONG WAIT FOR FDA ACTION28 pagesOversight and Government Reform CommitteeJul 27, 2023

CRS reports 3

Congressional Research Service work that CRS links to this bill or the law it became, newest first.

Cite it 3

Products on other subjects that cite it, usually among other measures.

ProductTitleKindPublished
IF13136Changes to the Statutory Definition of Hemp and Implications for Agricultural PolicyResourceMay 28, 2026
IF12278Farm Bill Primer: Hemp Industry Support and Regulation ArchivedResourceJan 10, 2025
IF12477FDA’s Oversight of Hemp-Derived Compounds ArchivedResourceAug 18, 2023

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
To authorize the regulation of interstate commerce with respect to food containing cannabidiol derived from hemp, and for other purposes.
Short Title(s) as Introduced
CBD Product Safety and Standardization Act of 2023

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Mar 17, 2023Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.